+91 - 830 - 3146878
A retrospective pilot clinical study was carried out for evaluation of cancero-static effects of LAS01- an Ayurvedic herbo-mineral compound in human subjects Guidelines as prescribed by W.H.O., ICMR and Ayurvedic Pharmacopoeia of India (A.P.I.) were followed for this study. Patients suffering from Cancer (CA) of Gall bladder were selected from the OPD of Lavanya hospital. The formulation LAS01 was prepared containing many metallic and minerals substances like Gold, Silver, and Copper; Sulphur, Mica, Arsenic and large number of drugs of vegetable origin.
These ingredients were subjected to various processes viz Sanskaras for removing toxic effects of these substances by following procedures as laid down in ancient Ayurvedic texts and Ayurvedic Pharmacopoeia of India (A.P.I.). Patients were given the drug one gram twice daily orally after meals however doses were regulated according to the severity of the disease, if required. A feeling of well-being was observed in a short span of two weeks after treatment with LAS01 while biochemical and radiological parameters did not show any significant changes after 30 days or more time period after treatment with LAS01. It was also observed that the growths of the cancer as well as metastasis were checked besides the amelioration of adverse effects of the modern chemotherapy which also subsided gradually.
Live cell imagining and proliferation data demonstrate that most effective and time-depended anti-tumor activity was observed at 25μg/ml treatment dose of LAS01 agent with MDA0132 and HT-29 Micro tumors. Both agents may have some inhibitory effects at higher dose (100ug) and/or longer treatment days (> 7-10 day). Future evaluation of anti-tumor profiles at lower concentrations of LAS01 using various other tumor cell lines and potential biomarker and genomic analysis for mechanistic studies.
Urinary bladder cancer is fourth most common cancer in men hence it has ever been attracting the attention of medical field for search of a safe and effective treatment for recovery from it. As it induces a poor quality of life (QOL) despite aggressive treatment with radical cystectomy, primary Transitional Cell Carcinoma (TCC) of bladder is relatively common tumor with a risk of its recurrence.
As the W.H.O. has been advocating for search of newer modalities for the treatment of TCC, an Ayurvedic coded herbomineral formulation (LAS01) was evaluated in such cases so as to find out a safe, effective and indigenous treatment.
Alternative systems of medicine including Ayurveda has remedies for terminal diseases like Cancers. A herbo-mineral formulations (LAS-01) developed by Lavanya Ayurvedic was employed any case of Non Hodgkin’s Lymphoma under permission of IEC of Hospital. The patient was closely monitored for day to day effects of the formulations. After Chemotherapy and Radiation with no remedial effects, the case (N.A.) was admitted for his treatment at Lavanya Ayurveda Hospital.
In a short span of treatment, marked clinical and radiological effects were observed. The patient felt a for better improvement in comparison of modern treatment in healing of nasal wound and quality of life (QOL).
The purpose of this study was to evaluate the acute oral toxicity study of LAS02 in female Sprague Dawley rat model. [...]
The purpose of this study was to evaluate the maximum tolerated dose of LAS02 in Sprague dawley female rat. [...]
The aim of this study was to evaluate the maximum tolerated dose of LAS02 in female Sprague Dawley rat. [...]